371 related articles for article (PubMed ID: 21404331)
1. Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies.
Costa A; Riedel M; Müller U; Möller HJ; Ettinger U
Synapse; 2011 Oct; 65(10):998-1005. PubMed ID: 21404331
[TBL] [Abstract][Full Text] [Related]
2. Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3.
van de Giessen E; de Win MM; Tanck MW; van den Brink W; Baas F; Booij J
J Nucl Med; 2009 Jan; 50(1):45-52. PubMed ID: 19091889
[TBL] [Abstract][Full Text] [Related]
3. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.
van Dyck CH; Malison RT; Jacobsen LK; Seibyl JP; Staley JK; Laruelle M; Baldwin RM; Innis RB; Gelernter J
J Nucl Med; 2005 May; 46(5):745-51. PubMed ID: 15872345
[TBL] [Abstract][Full Text] [Related]
4. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans.
Martinez D; Gelernter J; Abi-Dargham A; van Dyck CH; Kegeles L; Innis RB; Laruelle M
Neuropsychopharmacology; 2001 May; 24(5):553-60. PubMed ID: 11282255
[TBL] [Abstract][Full Text] [Related]
5. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele.
Krause J; Dresel SH; Krause KH; La Fougère C; Zill P; Ackenheil M
World J Biol Psychiatry; 2006; 7(3):152-7. PubMed ID: 16861140
[TBL] [Abstract][Full Text] [Related]
6. Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics.
Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gassó P; Catalan R; Mateos JJ; Lomeña F; Parellada E
Schizophr Res; 2007 Feb; 90(1-3):115-22. PubMed ID: 17150335
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate effects on brain activity as a function of SLC6A3 genotype and striatal dopamine transporter availability.
Kasparbauer AM; Rujescu D; Riedel M; Pogarell O; Costa A; Meindl T; la Fougère C; Ettinger U
Neuropsychopharmacology; 2015 Feb; 40(3):736-45. PubMed ID: 25220215
[TBL] [Abstract][Full Text] [Related]
8. Genotype influences in vivo dopamine transporter availability in human striatum.
Heinz A; Goldman D; Jones DW; Palmour R; Hommer D; Gorey JG; Lee KS; Linnoila M; Weinberger DR
Neuropsychopharmacology; 2000 Feb; 22(2):133-9. PubMed ID: 10649826
[TBL] [Abstract][Full Text] [Related]
9. Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects.
Spencer TJ; Biederman J; Faraone SV; Madras BK; Bonab AA; Dougherty DD; Batchelder H; Clarke A; Fischman AJ
Biol Psychiatry; 2013 Jul; 74(2):84-9. PubMed ID: 23273726
[TBL] [Abstract][Full Text] [Related]
10. Influence of genotype on dopamine transporter availability in human striatum and sleep architecture.
Guindalini C; Martins RC; Andersen ML; Tufik S
Psychiatry Res; 2010 Sep; 179(2):238-40. PubMed ID: 20493539
[TBL] [Abstract][Full Text] [Related]
11. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
Bonvicini C; Faraone SV; Scassellati C
Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
[TBL] [Abstract][Full Text] [Related]
12. Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis.
Faraone SV; Spencer TJ; Madras BK; Zhang-James Y; Biederman J
Mol Psychiatry; 2014 Aug; 19(8):880-9. PubMed ID: 24061496
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant treatment effects on dopamine transporter availability in patients with major depression: a prospective
Hellwig S; Frings L; Masuch A; Vach W; Domschke K; Normann C; Meyer PT
J Neural Transm (Vienna); 2018 Jun; 125(6):995-1005. PubMed ID: 29476250
[TBL] [Abstract][Full Text] [Related]
14. Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers--a SPECT study.
Chen PS; Yeh TL; Lee IH; Lin CB; Tsai HC; Chen KC; Chiu NT; Yao WJ; Yang YK; Chou YH
Neuroimage; 2011 Jun; 56(3):1526-30. PubMed ID: 21371559
[TBL] [Abstract][Full Text] [Related]
15. SLC6A3 gene polymorphisms are associated with striatal dopamine transporter changes after glucose loading.
Pak K; Seo S; Kim K; Lee MJ; Kim IJ
Synapse; 2022 Feb; 76(1-2):e22223. PubMed ID: 35098587
[TBL] [Abstract][Full Text] [Related]
16. The role of the SLC6A3 3' UTR VNTR in nicotine effects on cognitive, affective, and motor function.
Schröder R; Reuter M; Faßbender K; Plieger T; Poulsen J; Lui SSY; Chan RCK; Ettinger U
Psychopharmacology (Berl); 2022 Feb; 239(2):489-507. PubMed ID: 34854936
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the association of the SLC6A3 3'-UTR VNTR with cognition.
Ettinger U; Merten N; Kambeitz J
Neurosci Biobehav Rev; 2016 Jan; 60():72-81. PubMed ID: 26593110
[TBL] [Abstract][Full Text] [Related]
18. Prediction of dopamine transporter binding availability by genotype: a preliminary report.
Jacobsen LK; Staley JK; Zoghbi SS; Seibyl JP; Kosten TR; Innis RB; Gelernter J
Am J Psychiatry; 2000 Oct; 157(10):1700-3. PubMed ID: 11007732
[TBL] [Abstract][Full Text] [Related]
19. A variable number of tandem repeats in the 3'-untranslated region of the dopamine transporter modulates striatal function during working memory updating across the adult age span.
Sambataro F; Podell JE; Murty VP; Das S; Kolachana B; Goldberg TE; Weinberger DR; Mattay VS
Eur J Neurosci; 2015 Aug; 42(3):1912-8. PubMed ID: 25997640
[TBL] [Abstract][Full Text] [Related]
20. A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.
Šerý O; Paclt I; Drtílková I; Theiner P; Kopečková M; Zvolský P; Balcar VJ
Behav Brain Funct; 2015 Jun; 11():21. PubMed ID: 26058807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
